PROM1 and ovarian carcinoma: For instance, CD133 + ovarian cancer cells demonstrate heightened clonogenic and proliferative potential than CD133- cells, while elevated CD44 expression closely correlates with a poor prognosis of plasma ovarian cancer [12].